Tackling Immigrant Bias in Clinical Trials with David Rosenbaum
In this episode, Maya meets David Rosenbaum to talk about immigrants in clinical trials. David helps scatter the immigrant bias with clinical trials in Turkey and other Balkan countries. However, it’s an ongoing administrative effort.
David is the Founder of Rosenbaum Group. It is a CRO operating since 2019 in the south-eastern Balkans and Turkey. The organization focuses on clinical trials in CNS, infectious diseases, and gastroenterology. It also supports BIOTECH research and medical devices with a patient-centric approach.
Maya and David discuss the following topics:
(2:30) Immigrant story from a clinical trial in Turkey
(7:12) What makes immigrants vulnerable patients
(9:50) The situation with immigrants and trials in the Balkans
(12:48) Ways to improve communication with authorities
(16:06) Tech portals vs direct communication with regulatory bodies
(19:40) What can ethics committees improve further
(23:02) The #1 thing to make trial patient-friendly
Tune in today for a thrilling journey into clinical trials – expand your knowledge!
Maya Zlatanova, CEO of Trialhub
David Rosenbaum, Clinical Trial Manager @ Rosenbaum Group Ltd.
See More:
